129 related articles for article (PubMed ID: 30655324)
21. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
[TBL] [Abstract][Full Text] [Related]
22. Estrogen receptor alpha and the activating protein-1 complex cooperate during insulin-like growth factor-I-induced transcriptional activation of the pS2/TFF1 gene.
Baron S; Escande A; Albérola G; Bystricky K; Balaguer P; Richard-Foy H
J Biol Chem; 2007 Apr; 282(16):11732-41. PubMed ID: 17317669
[TBL] [Abstract][Full Text] [Related]
23. RASSF1A inhibits estrogen receptor alpha expression and estrogen-independent signalling: implications for breast cancer development.
Thaler S; Schmidt M; Schad A; Sleeman JP
Oncogene; 2012 Nov; 31(47):4912-22. PubMed ID: 22266866
[TBL] [Abstract][Full Text] [Related]
24. A role for CBFβ in maintaining the metastatic phenotype of breast cancer cells.
Ran R; Harrison H; Syamimi Ariffin N; Ayub R; Pegg HJ; Deng W; Mastro A; Ottewell PD; Mason SM; Blyth K; Holen I; Shore P
Oncogene; 2020 Mar; 39(12):2624-2637. PubMed ID: 32005976
[TBL] [Abstract][Full Text] [Related]
25. Requirement of protein l-isoaspartyl O-methyltransferase for transcriptional activation of trefoil factor 1 (TFF1) gene by estrogen receptor alpha.
Park JW; Lee JC; Ha SW; Bang SY; Park EK; Yi SA; Lee MG; Kim DS; Nam KH; Yoo JH; Kwon SH; Han JW
Biochem Biophys Res Commun; 2012 Apr; 420(2):223-9. PubMed ID: 22382029
[TBL] [Abstract][Full Text] [Related]
26. Williams syndrome transcription factor (WSTF) acts as an activator of estrogen receptor signaling in breast cancer cells and the effect can be abrogated by 1α,25-dihydroxyvitamin D
Lundqvist J; Kirkegaard T; Laenkholm AV; Duun-Henriksen AK; Bak M; Feldman D; Lykkesfeldt AE
J Steroid Biochem Mol Biol; 2018 Mar; 177():171-178. PubMed ID: 28610873
[TBL] [Abstract][Full Text] [Related]
27. Genetic evidence of PEBP2beta-independent activation of Runx1 in the murine embryo.
Yokomizo T; Yanagida M; Huang G; Osato M; Honda C; Ema M; Takahashi S; Yamamoto M; Ito Y
Int J Hematol; 2008 Sep; 88(2):134-138. PubMed ID: 18594778
[TBL] [Abstract][Full Text] [Related]
28. Indispensable role of the Runx1-Cbfbeta transcription complex for in vivo-suppressive function of FoxP3+ regulatory T cells.
Kitoh A; Ono M; Naoe Y; Ohkura N; Yamaguchi T; Yaguchi H; Kitabayashi I; Tsukada T; Nomura T; Miyachi Y; Taniuchi I; Sakaguchi S
Immunity; 2009 Oct; 31(4):609-20. PubMed ID: 19800266
[TBL] [Abstract][Full Text] [Related]
29. Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα.
Bloomfield M; Louie MC
Sci Rep; 2019 Aug; 9(1):12135. PubMed ID: 31431634
[TBL] [Abstract][Full Text] [Related]
30. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
[TBL] [Abstract][Full Text] [Related]
31. RUNX1 as a Novel Molecular Target for Breast Cancer.
Ariffin NS
Clin Breast Cancer; 2022 Aug; 22(6):499-506. PubMed ID: 35599145
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of cooperative binding of transcription factors Runx1-CBFβ-Ets1 on the TCRα gene enhancer.
Kasahara K; Shiina M; Fukuda I; Ogata K; Nakamura H
PLoS One; 2017; 12(2):e0172654. PubMed ID: 28231333
[TBL] [Abstract][Full Text] [Related]
33. AIB1:ERα transcriptional activity is selectively enhanced in aromatase inhibitor-resistant breast cancer cells.
O'Hara J; Vareslija D; McBryan J; Bane F; Tibbitts P; Byrne C; Conroy RM; Hao Y; Gaora PÓ; Hill AD; McIlroy M; Young LS
Clin Cancer Res; 2012 Jun; 18(12):3305-15. PubMed ID: 22550166
[TBL] [Abstract][Full Text] [Related]
34. Runx1 regulates Tff1 expression to expedite viability of retinal microvascular endothelial cells in mice with diabetic retinopathy.
Zhang W; Zhang D; Cheng Y; Liang X; Wang J
Exp Eye Res; 2022 Apr; 217():108969. PubMed ID: 35114215
[TBL] [Abstract][Full Text] [Related]
35. Chromatin modification of the trefoil factor 1 gene in human breast cancer cells by the Ras/mitogen-activated protein kinase pathway.
Espino PS; Li L; He S; Yu J; Davie JR
Cancer Res; 2006 May; 66(9):4610-6. PubMed ID: 16651411
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of BTF3 sensitizes luminal breast cancer cells to PI3Kα inhibition through the transcriptional regulation of ERα.
Ding J; Wang X; Zhang Y; Sang X; Yi J; Liu C; Liu Z; Wang M; Zhang N; Xue Y; Shen L; Zhao W; Luo F; Liu P; Cheng H
Cancer Lett; 2019 Jan; 440-441():54-63. PubMed ID: 30315845
[TBL] [Abstract][Full Text] [Related]
37. Estrogen receptor α promotes protein synthesis by fine-tuning the expression of the eukaryotic translation initiation factor 3 subunit f (eIF3f).
Cuesta R; Berman AY; Alayev A; Holz MK
J Biol Chem; 2019 Feb; 294(7):2267-2278. PubMed ID: 30573685
[TBL] [Abstract][Full Text] [Related]
38. Trefoil factor-1 upregulation in estrogen-receptor positive breast cancer correlates with an increased risk of bone metastasis.
Spadazzi C; Mercatali L; Esposito M; Wei Y; Liverani C; De Vita A; Miserocchi G; Carretta E; Zanoni M; Cocchi C; Bongiovanni A; Recine F; Kang Y; Ibrahim T
Bone; 2021 Mar; 144():115775. PubMed ID: 33249323
[TBL] [Abstract][Full Text] [Related]
39. KISS1R induces invasiveness of estrogen receptor-negative human mammary epithelial and breast cancer cells.
Cvetkovic D; Dragan M; Leith SJ; Mir ZM; Leong HS; Pampillo M; Lewis JD; Babwah AV; Bhattacharya M
Endocrinology; 2013 Jun; 154(6):1999-2014. PubMed ID: 23525242
[TBL] [Abstract][Full Text] [Related]
40. BRCA2 represses the transcriptional activity of pS2 by E2-ERα.
Fukuda M; Tojo Y; Sato A; Saito H; Nakanishi A; Miki Y
Biochem Biophys Res Commun; 2022 Jan; 588():75-82. PubMed ID: 34952473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
